Table 2.
Survival at different times of follow-up for different endpoints
| Re-revision | 10-year failure rate (95% CI) | Number at risk | 15-year failure rate (95% CI) | Number at risk | 20-year failure rate (95% CI) | Number at risk |
| Survival complete revision THA | ||||||
| Re-revision for any reason (events = 11) | 13% (4 to 26) | 22 | 27% (13 to 44) | 13 | 38% (19 to 57) | 4 |
| Re-revision for aseptic loosening (events = 6) | 3% (0 to 13) | 22 | 10% (3 to 25) | 13 | 21% (7 to 40) | 4 |
| Reoperation for any reason (events = 12) | 22% (10 to 37) | 19 | 30% (15 to 46) | 12 | 41% (22 to 60) | 3 |
| Survival acetabular components only | ||||||
| Re-revision for any reason (events = 11) | 13% (4 to 26) | 22 | 27% (13 to 44) | 13 | 38% (19 to 57) | 4 |
| Re-revision for aseptic loosening (events = 6) | 3% (0 to 13) | 22 | 10% (3 to 25) | 13 | 21% (7 to 40) | 4 |
| Reoperation for any reason (events = 12) | 22% (10 to 37) | 19 | 30% (15 to 46) | 12 | 41% (22 to 60) | 3 |
| Survival femoral components only | ||||||
| Re-revision for any reason (events = 7) | 10% (2 to 23) | 23 | 21% (8 to 37) | 14 | 21% (8 to 37) | 4 |
| Re-revision for aseptic loosening (events = 2) | 0% (NA) | 23 | 4% (0 to 16) | 14 | 4% (0 to 16) | 4 |
| Reoperation for any reason (events = 8) | 19% (8 to 34) | 20 | 23% (10 to 39) | 13 | 23% (10 to 39) | 3 |